News

Arriva Pharmaceuticals Forms Scientific Advisory Board
Dated: 14 January 2009
Arriva Pharmaceuticals Granted Protein Production Patent - Patent strengthens company's position for development of lead product.
Dated: 1 October 2008
 
Arriva Pharmaceuticals Granted Fusion Protein Patent - Intellectual property provides strong position for development of therapy for asthma.
Dated: 21 May 2008
 
Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema.
Dated: 28 February 2008